SCAL (SCAL) Stock Price & Analysis
SCAL (SCAL) rose 0.00% to USD 0 as of June 10, 2026 at 07:40 UTC, according to Nexqual real-time market data.
SCAL last closed at USD 0; the session ranged USD 0–0 on volume of 23,100 shares. Market capitalization is $194,170, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 07:40 UTC.
Key Statistics (as of June 10, 2026 at 07:40 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 23,100 shares |
| Market Cap | $194,170 |
| Exchange | PNK |
Technical Analysis (SCAL)
Nexqual's technical model rates SCAL "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:40 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (SCAL)
Wall Street analysts rate SCAL "None", per Nexqual as of June 10, 2026 at 07:40 UTC.
| Consensus Rating | None |
|---|
Earnings (SCAL)
Source: Nexqual, June 10, 2026 at 07:40 UTC.
Financials & Fundamentals (SCAL)
| Total Revenue | $3.33M |
|---|---|
| Gross Margin | +68.18% |
| Operating Margin | +38.37% |
| Profit Margin | +55.06% |
| Debt / Equity | 488.28 |
| Current Ratio | 1.12 |
| Total Cash | $39,841 |
| Total Debt | $2.22M |
Source: Nexqual, June 10, 2026 at 07:40 UTC.
Financial Health Score (SCAL)
Nexqual rates SCAL's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 07:40 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Critical — $40K cash vs $2M debt |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (SCAL)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 970.85M |
Source: Nexqual, June 10, 2026 at 07:40 UTC.
Leadership (SCAL)
SCAL is led by Carlzo Bernard Cardwell, Founder, CEO & President, per Nexqual as of June 10, 2026 at 07:40 UTC.
| Founder, CEO & President | Carlzo Bernard Cardwell |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CCEL | Cryo-Cell International, Inc. | USD 3.45 | ▼ 1.43% |
| MCET | MULTICELL TECHNOLOGIES INC | USD 0 | ▲ 0% |
| SCII | SC II Acquisition Corp. | USD 10.04 | ▲ 0% |
| ISCO | International Stem Cell Corp. | USD 0.17 | ▼ 5.56% |
| STSN | Stemsation International, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:40 UTC. This page is informational and not investment advice.